Drug Discovery Solutions

  1. CHEF1™ Expression Technology 2/17/2022

    The platform accelerates development of cell lines for cGMP production by using robust procedures and reliable raw materials, including chemically defined media, adapted Chinese hamster ovary (CHO) cells, and proprietary expression plasmids, to rapidly produce high levels of recombinant protein.

  2. LV Edge System 11/24/2025

    By transitioning from a 4-plasmid transient system to 1- or 0-plasmid configurations, the LV Edge systems reduce or eliminate the need for GMP plasmids, lowering costs and supply chain risks.

  3. Multi-Discipline Drug Discovery Capabilities & Deep Expertise Within The Drug Development Pathway 5/11/2021

    Learn about the Specialized Services that customers often seek that require a discrete expertise and technology toolbox not found in many CRO/CDMOs.

  4. Designed For Inhalation: Pulmonary And Nasal Delivery

    Our newly expanded in-house capabilities span clinical and commercial scale manufacturing for DPIs, unit-dose, bi-dose and preserved multi-dose nasal sprays.

  5. SUREmAb — Monoclonal Antibody Development, The Way It's Meant To Be 8/4/2023

    Leverage robust development strategies and enable an optimized process for mAb development and manufacturing, efficiency and speed with exceptional quality, and high titers with lower-cost workflows for maximum ROI.

  6. Leveraging Proprietary CDO Platforms

    Explore how a suite of proprietary CDO platforms for BsAbs, transient expression, developability assessment, and more can help optimize every stage of development and accelerate your project timeline.

  7. Advance Your Oncology Research With Discovery Services 8/26/2025

    Find discovery oncology solutions that consist of in vitro assessments, in vivo pharmacology services, in vivo imaging technologies and focal radiation capabilities to support your oncology research programs.

  8. A Fully Integrated Toolbox For Therapeutic Protein Expression

    The GS Xceed® Gene Expression System is a comprehensive toolbox for development of biologics that has been used to develop not only monoclonal antibodies but also a wide variety of new molecular formats.

  9. Discover A Platform For Antibodies With Increased ADCC Activity 5/15/2023

    Explore a platform for antibodies with increased ADCC activity that's compatible with various host cell lines, works across multiple vector configurations, and reduces core fucose within any cell line.

  10. iPSC Generation Services 9/30/2025

    iPSC generation is a complex process of reprogramming adult somatic cells into a pluripotent, embryonic stem cell-like stage.